Ross operation in a patient with juvenile rheumatoid arthritis.

G. Melina,M. Sheppard,J. Pepper

DOI: https://doi.org/10.1016/j.athoracsur.2010.05.057

2010-08-01

Abstract:

What problem does this paper attempt to address?

Severe KIDAR syndrome caused by deletion in the AP1B1 gene: Report of a teenage patient and systematic review of the literature

Alice P Vasconcelos,Ana Nogueira,Pedro Matos,Joel Pinto,Maria João Pinho,Susana Fernandes,Sofia Dória,Carla Pinto Moura

DOI: https://doi.org/10.1016/j.ejmg.2023.104827

Abstract:Autosomal recessive keratitis-ichthyosis-deafness syndrome (KIDAR MIM #242150) is a very rare disorder caused by pathogenic loss-of-function variants in the AP1B1 gene. So far, nine patients have been reported in the literature and more clinical descriptions are essential to further delineate the phenotype of KIDAR. Here we report a new patient with KIDAR and compare the clinical findings with those from the other published cases with molecular confirmation. We describe a 14-year-old male born to non-consanguineous parents with unremarkable family history. The patient had fetal ascites, neonatal pancreatic insufficiency with consequent failure to thrive, feeding difficulties, recurrent infections and sepsis. The skin examination was remarkable for an ichthyosis with conspicuous palmoplantar keratoderma, sparse and brittle hair with alopecia on the vertex and slight bilateral ectropion. He had short stature, thin build, frontal bossing, small teeth and prominent abdomen. Additional features were congenital profound bilateral sensorineural deafness, photosensitivity and photophobia. Mild global developmental delay was noted. Persistent mild anemia, neutropenia, thrombocytopenia, and low serum copper, ceruloplasmin and growth hormone were also present. Brain magnetic resonance imaging (MRI) showed cerebral atrophy and thin corpus callosum. Genetic testing revealed a homozygous deletion in the AP1B1 gene, possibly including the same exons as a previously reported deletion. Comparing the phenotypes of all reported individuals, they are highly concordant and major features are enteropathy with feeding difficulties, failure to thrive, ichthyosis, palmoplantar keratoderma, sensorineural deafness and sparse and brittle hair. Here we report other features present in more than one patient that could be part of the phenotypic spectrum and suggest copy number variation analysis to be performed alongside sequencing of the AP1B1 gene in case of suspicion.
Integrated Facial Analysis and Targeted Sequencing Identifies a Novel KDM6A Pathogenic Variant Resulting in Kabuki Syndrome

Shi Weihui,Chen Yiyao,Chen Songchang,Li Shuyuan,Chang Chunxin,Zhang Lanlan,Fei Hongjun,Huang Hefeng,Zhang Junyu,Xu Chenming

DOI: https://doi.org/10.1097/jbr.0000000000000022

2018-01-01

Abstract:Abstract Kabuki syndrome (KS) is a rare congenital mental retardation condition characterized by facial dysmorphia, visceral and skeletal malformations, and developmental delay. The integrated phenotype and genotype-based prioritization is critical for diagnoses of genetic diseases. In this study, a Chinese woman, presenting with characteristic facial features of KS, came for pre-pregnancy consultation. We aimed to clarify the diagnosis and provide pre-pregnancy genetic counseling. Facial dysmorphology analysis and next-generation sequencing-based multigene panel approach were used to identify candidate syndromes and causative variants, respectively. The candidate variant was verified by Sanger sequencing. We identified a novel de novo KDM6A pathogenic variant (c.3521G>A) in the woman, which was in line with the Face2Gene analysis result. Peripheral blood RNA assay showed that the variant transcript underwent the nonsense-mediated mRNA decay and led to subsequent haploinsufficiency of KDM6A. Our study provides the genetic diagnosis method for KS type 2 and identifies the first KDM6A point variant in Chinese patient.
Intersession repeatability of visual acuity scores in age-related macular degeneration.

P. Patel,F. Chen,G. Rubin,A. Tufail

DOI: https://doi.org/10.1167/iovs.08-1935

2008-10-01

Investigative Ophthalmology and Visual Science

Abstract:PURPOSE To describe the intersession repeatability of visual acuity measures obtained with Early Treatment of Diabetic Retinopathy Study (ETDRS) charts in patients with age-related macular degeneration. METHODS Visual acuity was measured in four sessions over 12 weeks using a standardized protocol with ETDRS charts in 107 nontreated eyes of 107 patients with age-related macular degeneration enrolled in an ongoing clinical trial. RESULTS Data from 90 patients were included in the analysis. The 95% coefficient of repeatability (CR) was 12 ETDRS letters and ranged from 9 letters for 29 eyes with small to intermediate drusen only to 17 letters for 25 eyes with late AMD (macular scars or geographic atrophy). Ten (11%) eyes had a 5-letter reduction or more in visual acuity at the week 1 visit compared with baseline. Excluding seven eyes with visual acuity measurements potentially affected by measurement-related factors (a change in testing distance between visits) the revised CR was 10 letters for the cohort (n = 83) and 11 letters for the late-AMD subgroup (n = 18). CONCLUSIONS Intersession ETDRS visual acuity measurements are subject to considerable variability in patients with AMD. The variability may be due to both measurement- and disease-related factors. The variable readings have implications for AMD clinical trial design and for the assessment and treatment of patients with neovascular AMD. Further work is needed to determine both the sources of variability in visual acuity measurements and the optimal change criterion for visual acuity measurements in this important group of patients.
Poster presentationsSG11 KRT14 pathogenic or likely pathogenic variants beyond epidermolysis bullosa: dermatopathia pigmentosa reticularis

Schaida Schirwani,Mira Kharbanda

DOI: https://doi.org/10.1093/bjd/ljae090.393

IF: 11.113

2024-06-28

British Journal of Dermatology

Abstract:Abstract The KRT14 gene is 4615 base pairs long and has eight exons. It encodes the intermediate filament protein keratin 14, which is 472 amino acids long and has four helical domains flanked by a nonhelical head domain and tail domain. Keratin 14 partners with the keratin 5 protein, encoded by the KRT5 gene, to provide structural support in basal keratinocytes of the epidermis and to regulate the distribution of melanin. Variants in KRT14 are associated with distinct clinical phenotypes and interesting genotype–phenotype correlations. Dermatopathia pigmentosa reticularis (DPR), or Naegeli–Franceschetti–Jadassohn syndrome (NFJS), has been associated with frameshift and nonsense variants involving the nonhelical head domain of keratin 14. Frameshift and missense variants in other domains of the protein cause dominant and recessive forms of epidermolysis bullosa simplex. Five different KRT14 variants have been reported in seven families with NFJS/DPR, including the presented family. Until recently NFJS and DPR were considered separate disease entities, but recent research supports the view that they are a spectrum of the same condition. We present three generations of a family with DPR. The index case is a 20-year-old woman who, at the age of 8 years, was noted to have thickened skin on the soles of feet, brittle and thickened nails, and dental issues. On examination, she was found to have onycholysis of her fingernails, hypoplasia of her dermatoglyphs, onychogryphosis affecting all 10 toenails, and pitted palmoplantar keratoderma. Reticulate skin hyperpigmentation, which is a feature of this syndrome, was absent. She had extensive dental disease with multiple dental carries, and broken and missing teeth. She reported generalized hyperhidrosis, particularly severe axillary hyperhidrosis, and had noncicatricial alopecia. Her mother presented with features of the condition at a similar age. She had similar but milder features. She had onycholysis, a degree of onychogryphosis and some punctate plantar keratoderma. No hyperhidrosis or heat intolerance were reported. At the age of 43 years she had a full set of teeth with one dental extraction and one filling. The index patient’s maternal grandfather was reported to have similar nail and skin features. He was also reported to have lost most of his teeth at a young age. Genetic testing identified a heterozygous pathogenic variant 19C>T, p.GIn7Ter, in KRT14, which confirmed the diagnosis of DPR in the index case. The mother was found to carry the same variant. DPR is an ultrarare autosomal dominant ectodermal dysplasia characterized by reticulate hyperpigmentation (which may fade), nail dystrophy, keratoderma, hypo- or hyperhidrosis, hair abnormalities, dental disease and hypoplastic dermatoglyphs. Management focuses on symptomatic relief. A confirmed molecular diagnosis is important so patients can be offered appropriate medical and dental management and prenatal options, if they wish to pursue preimplantation genetic diagnosis.

dermatology
Antibody Deficiency in Patients with Biallelic KARS1 Mutations

Saettini Francesco,Guerra Fabiola,Fazio Grazia,Bugarin Cristina,McMillan Hugh J,Ohtake Akira,Ardissone Anna,Itoh Masayuki,Giglio Sabrina,Cappuccio Gerarda,Giardino Giuliana,Romano Roberta,Quadri Manuel,Gasperini Serena,Moratto Daniele,Chiarini Marco,Ishiguro Akira,Fukuhara Yasuyuki,Hayakawa Itaru,Okazaki Yasushi,Mauri Mario,Piazza Rocco,Cazzaniga Gianni,Biondi Andrea

DOI: https://doi.org/10.1007/s10875-023-01584-7

IF: 8.542

2023-09-28

Journal of Clinical Immunology

Abstract:Biallelic KARS1 mutations cause KARS-related diseases, a rare syndromic condition encompassing central and peripheral nervous system impairment, heart and liver disease, and deafness. KARS1 encodes the t-RNA synthase of lysine, an aminoacyl-tRNA synthetase, involved in different physiological mechanisms (such as angiogenesis, post-translational modifications, translation initiation, autophagy and mitochondrial function). Although patients with immune-hematological abnormalities have been individually described, results have not been collectively discussed and functional studies investigating how KARS1 mutations affect B cells have not been performed. Here, we describe one patient with severe developmental delay, sensoneurinal deafness, acute disseminated encephalomyelitis, hypogammaglobulinemia and recurrent infections. Pathogenic biallelic KARS1 variants (Phe291Val/ Pro499Leu) were associated with impaired B cell metabolism (decreased mitochondrial numbers and activity). All published cases of KARS-related diseases were identified. The corresponding authors and researchers involved in the diagnosis of inborn errors of immunity or genetic syndromes were contacted to obtain up-to-date clinical and immunological information. Seventeen patients with KARS-related diseases were identified. Recurrent/severe infections (9/17) and B cell abnormalities (either B cell lymphopenia [3/9], hypogammaglobulinemia [either IgG, IgA or IgM; 6/15] or impaired vaccine responses [4/7]) were frequently reported. Immunoglobulin replacement therapy was given in five patients. Full immunological assessment is warranted in these patients, who may require detailed investigation and specific supportive treatment.

immunology
Biallelic variants in KARS1 are associated with neurodevelopmental disorders and hearing loss recapitulated by the knockout zebrafish

Sheng-Jia Lin,Barbara Vona,Patricia G. Barbalho,Rauan Kaiyrzhanov,Reza Maroofian,Cassidy Petree,Mariasavina Severino,Valentina Stanley,Pratishtha Varshney,Paulina Bahena,Fatema Alzahrani,Amal Alhashem,Alistair T. Pagnamenta,Gudrun Aubertin,Juvianee I. Estrada-Veras,Héctor Adrián Díaz Hernández,Neda Mazaheri,Andrea Oza,Jenny Thies,Deborah L. Renaud,Sanmati Dugad,Jennifer McEvoy,Tipu Sultan,Lynn S. Pais,Brahim Tabarki,Daniel Villalobos-Ramirez,Aboulfazl Rad,Hamid Galehdari,Farah Ashrafzadeh,Afsaneh Sahebzamani,Kolsoum Saeidi,Erin Torti,Houda Z. Elloumi,Sara Mora,Timothy B. Palculict,Hui Yang,Jonathan D. Wren,Ben Fowler,Manali Joshi,Martine Behra,Shawn M. Burgess,Swapan K. Nath,Michael G. Hanna,Margaret Kenna,J. Lawrence Merritt,Henry Houlden,Ehsan Ghayoor Karimiani,Maha S. Zaki,Thomas Haaf,Fowzan S. Alkuraya,Joseph G. Gleeson,Gaurav K. Varshney,J.C. Ambrose,P. Arumugam,M. Bleda,F. Boardman-Pretty,C.R. Boustred,H. Brittain,M.J. Caulfield,G.C. Chan,T. Fowler,A. Giess,A. Hamblin,S. Henderson,T.J.P. Hubbard,R. Jackson,L.J. Jones,D. Kasperaviciute,M. Kayikci,A. Kousathanas,L. Lahnstein,S.E.A. Leigh,I.U.S. Leong,F.J. Lopez,F. Maleady-Crowe,L. Moutsianas,M. Mueller,N. Murugaesu,A.C. Need,P. O‘Donovan,C.A. Odhams,C. Patch,D. Perez-Gil,M.B. Pereira,J. Pullinger,T. Rahim,A. Rendon,T. Rogers,K. Savage,K. Sawant,R.H. Scott,A. Siddiq,A. Sieghart,S.C. Smith,A. Sosinsky,A. Stuckey,M. Tanguy,E.R.A. Thomas,S.R. Thompson,A. Tucci,E. Walsh,M.J. Welland,E. Williams,K. Witkowska,S.M. Wood

DOI: https://doi.org/10.1038/s41436-021-01239-1

IF: 8.864

2021-10-01

Genetics in Medicine

Abstract:Pathogenic variants in Lysyl-tRNA synthetase 1 (KARS1) have increasingly been recognized as a cause of early-onset complex neurological phenotypes. To advance the timely diagnosis of KARS1-related disorders, we sought to delineate its phenotype and generate a disease model to understand its function in vivo.

genetics & heredity
A Rare Deep Intronic Mutation of PKHD1 Gene, C.8798-459 C > A, Causes Autosomal Recessive Polycystic Kidney Disease by Pseudoexon Activation

Jing Chen,Na Ma,Xiaomeng Zhao,Wen Li,Qianjun Zhang,Shimin Yuan,Yue-Qiu Tan,Guangxiu Lu,Ge Lin,Juan Du

DOI: https://doi.org/10.1038/s10038-018-0550-8

2019-01-01

Journal of Human Genetics

Abstract:Autosomal recessive polycystic kidney disease (ARPKD), is a rare hepatorenal fibrocystic disorder primarily associated with progressive growth of multiple cysts in the kidneys causing progressive loss of renal function. The disease is linked to mutations in the PKHD1 gene. In this study, we describe the gene diagnosis and prenatal diagnosis for a consanguineous family with two fetuses diagnosed with polycystic kidney disease by fetal sonography during the pregnancy. Sequence analysis of cDNA synthesized from the PKHD1 mRNA of the second induced fetus identified a 111-nucleotide insert at the junction of exon 56 and 57 that originated from intervening sequence (IVS) 56. Further genomic sequencing of IVS 56 of the PKHD1 gene identified a rare homozygous deep intronic mutation (c.8798-459 C > A), which was inherited from the parents and not detectable in 100 unrelated control subjects. Moreover, we explored the pathogenicity of this deep intronic mutation by conducting a minigene splicing assay experiment, which demonstrated that the mutation causes a pseudoexon insertion, which results in a frameshift followed by a premature termination codon in exon 57. Eventually, the parents had a healthy baby by undergoing prenatal genetic diagnosis based on the targeted detection of the intron mutation. The newly identified deep intronic mutation is associated with a rare mechanism of abnormal splicing that expands the spectrum of known PKHD1 gene mutations. It can be used in evidence-based genetic and reproductive counseling for families with ARPKD.
Leopard-like retinopathy and severe early-onset portal hypertension expand the phenotype of KARS1-related syndrome: a case report

Francesca Peluso,Viviana Palazzo,Giuseppe Indolfi,Francesco Mari,Roberta Pasqualetti,Elena Procopio,Claudia Nesti,Renzo Guerrini,Filippo Santorelli,Sabrina Giglio

DOI: https://doi.org/10.1186/s12920-020-00863-1

2021-01-21

BMC Medical Genomics

Abstract:Abstract Background Mutations in lysyl-tRNA synthetase ( KARS1 ), an enzyme that charges tRNA with the amino acid lysine in both the cytoplasm and mitochondria, have been associated thus far with autosomal recessive Charcot–Marie–Tooth type CMTRIB, hearing loss type DFNB89, and mitochondrial encephalohepatopathy (MEH) featuring neurodevelopmental disorders with microcephaly, white matter changes, and cardiac and hepatic failure in less than 30 patients. Case presentation We report the clinical, biochemical and molecular findings of a 14-month-old girl with severe MEH compatible clinical features, profound sensorineural hearing loss, leopard spot retinopathy, pancytopenia, and advanced liver disease with portal hypertension leading to death at the age of 30 months. Conclusions Whole exome sequencing identified two rare variants in KARS1 gene. Our report expands the allelic and clinical features of tRNA synthase disorders. Moreover, with our report we confirm the usefulness of WES as first tier diagnostic method in infants with complex multisystem phenotypes.

genetics & heredity
PI4K2A deficiency causes innate error in intracellular trafficking with developmental and epileptic-dyskinetic encephalopathy

Hormos Salimi Dafsari,Joshua G Pemberton,Elizabeth A Ferrer,Tony Yammine,Chantal Farra,Mohammad Hasan Mohammadi,Ehsan Ghayoor Karimiani,Narges Hashemi,Mirna Souaid,Sandra Sabbagh,Paria Najarzadeh Torbati,Suliman Khan,Emmanuel Roze,Andres Moreno-De-Luca,Aida M Bertoli-Avella,Henry Houlden,Tamas Balla,Reza Maroofian

DOI: https://doi.org/10.1002/acn3.51634

Abstract:Objective: Intracellular signaling networks rely on proper membrane organization to control an array of cellular processes such as metabolism, proliferation, apoptosis, and macroautophagy in eukaryotic cells and organisms. Phosphatidylinositol 4-phosphate (PI4P) emerged as an essential regulatory lipid within organelle membranes that defines their lipid composition and signaling properties. PI4P is generated by four distinct phosphatidylinositol 4-kinases (PI4K) in mammalian cells: PI4KA, PI4KB, PI4K2A, PI4K2B. Animal models and human genetic studies suggest vital roles of PI4K enzymes in development and function of various organs, including the nervous system. Bi-allelic variants in PI4KA were recently associated with neurodevelopmental disorders (NDD), brain malformations, leukodystrophy, primary immunodeficiency, and inflammatory bowel disease. Here, we describe patients from two unrelated consanguineous families with PI4K2A deficiency and functionally explored the pathogenic mechanism. Methods: Two patients with PI4K2A deficiency were identified by exome sequencing, presenting with developmental and epileptic-dyskinetic encephalopathy. Neuroimaging showed corpus callosum dysgenesis, diffuse white matter volume loss, and hypoplastic vermis. In addition to NDD, we observed recurrent infections and death at toddler age. We further explored identified variants with cellular assays. Results: This clinical presentation overlaps with what was previously reported in two affected siblings with homozygous nonsense PI4K2A variant. Cellular studies analyzing these human variants confirmed their deleterious effect on PI4K2A activity and, together with the central role of PI4K2A in Rab7-associated vesicular trafficking, establish a link between late endosome-lysosome defects and NDD. Interpretation: Our study establishes the genotype-phenotype spectrum of PI4K-associated NDD and highlights several commonalities with other innate errors of intracellular trafficking.
Genetic and phenotypic heterogeneity in KIAA0753-related ciliopathies

Katherine A Inskeep,Yuri A Zarate,Danielle Monteil,Jurgen Spranger,Dan Doherty,Rolf W Stottmann,K Nicole Weaver

DOI: https://doi.org/10.1002/ajmg.a.62497

Abstract:Primary ciliopathies are heterogenous disorders resulting from perturbations in primary cilia form and/or function. Primary cilia are cellular organelles which mediate key signaling pathways during development, such as the sonic hedgehog (SHH) pathway which is required for neuroepithelium and central nervous system development. Joubert syndrome is a primary ciliopathy characterized by cerebellar/brain stem malformation, hypotonia, and developmental delays. At least 35 genes are associated with Joubert syndrome, including the gene KIAA0753, which is part of a complex required for primary ciliogenesis. The phenotypic spectrum associated with biallelic pathogenic variants in KIAA0753 is broad and not well-characterized. We describe four individuals with biallelic pathogenic KIAA0753 variants, including five novel variants. We report in vitro results assessing the function of each variant indicating that mutant proteins are not fully competent to promote primary ciliogenesis. Ablation of KIAA0753 in vitro blocks primary ciliogenesis and SHH pathway activity. Correspondingly, KIAA0753 patient fibroblasts have a deficit in primary ciliation and improper SHH and WNT signaling, with a particularly blunted response to SHH pathway stimulation. Our work expands the phenotypic spectrum of KIAA0753 ciliopathies and demonstrates the utility of patient-focused functional assays for proving causality of genetic variants.
A Case of Noonan Syndrome and Kyrle's Disease: Coincidence or Causality?

Marco Brusasco,Arlind Kalaja,Francesca Satolli,Claudio Feliciani,Maria Beatrice De Felici Del Giudice

Abstract:A 39-year-old Caucasian woman affected by Noonan Syndrome (NS) mutated in RAF1 was referred to us with itchy lesions on her limbs that had appeared two months earlier. Clinically, there were multiple umbilicated papules with a hyperkeratotic central plug, localized on the upper and lower limbs (Figure 1, a-b). The patient had no personal history of diabetes mellitus and no chronic renal failure, but suffered from hypertrophic cardiomyopathy. Blood tests showed no abnormalities. On histological examination of a skin lesion, an ectatic hair follicle with hyperkeratotic ostium was observed with fragments of hair, inflammatory cells, and epidermal perforation. A final diagnosis of Kyrle's disease (KD) was established. The patient underwent narrowband UVB (NB-UVB) phototherapy with residual atrophic scars (Figure 1, c-d) but with complete and long-lasting resolution of symptoms as well. KD belongs to perforating dermatoses (PD), a heterogeneous group of skin diseases characterized by the transepidermal elimination of dermal components. Despite the classification of PD being debated, four primary forms are traditionally recognized: reactive perforating collagenosis, elastosis perforans serpiginosum, perforating folliculitis, and KD (1). The typical skin manifestation of KD is an eruption of dome-shaped papules and nodules with a whitish central keratotic plug, mainly localized on the extremities and the buttocks. Described by Kyrle in 1916, KD is frequently associated with systemic diseases, especially chronic renal failure and diabetes mellitus. Other associated conditions include chronic hepatic disease, internal malignancies, and congestive heart disease (1). Despite the absence of a consensus, the control of the underlying disease remains the first therapeutic target. Both topical (keratolytics, retinoids, and corticosteroids) and systemic treatments (corticosteroid, retinoids, antibiotics, and phototherapy) have been reported to control skin manifestations (2). In our experience, NB-UVB is an effective option as first-line therapy in case of diffuse lesions, both in KD and in other PDs (3). NS is a relatively common RASopathy, an heterogenous group of genetic disease characterized by a defect of the Ras-mitogen-activated protein kinase (Ras-MAPK) pathway, with an estimated prevalence of 1/1000-2500. PTPN11 is the most frequent mutated gene, accounting for 50% of cases, but more than ten genes were identified as causing NS (4). Classical features include a distinctive facial dysmorphism, short stature, pulmonic stenosis, and other anomalies of different organs. The skin is commonly involved. Keratinization disorders and hair abnormalities such as keratosis pilaris, ulerythema ophryogenes, wavy or curly hair, and scarce scalp hair are often described. Other cutaneous signs include easy bruising, skin hyperlaxity, multiple lentigines, and café-au-lait spots (5). To the best of our knowledge, no cases of KD in patients with NS have been previously reported to date. The exact etiopathogenesis of KD is not clear, but it was hypothesized that systemic diseases, such as diabetes and chronic renal failure, can cause a deposit of substances or dermis alterations, which triggers the inflammatory process with subsequent transepidermal extrusion (1). In our patient, we ruled out all the causes commonly associated with KD. It is however possible that this manifestation could be a direct result of our patient's illness. Our patient suffered from diffuse keratosis pilaris, and one of the possible pathogenetic mechanisms of KD was theorized to be an abnormal epidermal keratinization with a secondary inflammatory dermic response (1). On the other hand, the hyperlaxity and fragility of the skin typical of NS suggest the presence of altered connective tissue, which could trigger an abnormal keratinization and, subsequently, the transepidermal extrusion, as well as perforating elastosis, and is associated with genetic connective tissue diseases (1). Moreover, our patient suffered from a cardiac disease, another condition associated with KD (5). Although these explanations have their appeal, there is currently insufficient evidence of a link between KD and NS, and it will be necessary to collect additional data to confirm this hypothesis.
O18 Precision genome editing for targeted correction of pathogenic D50N mutation in keratitis–ichthyosis–deafness syndrome using CRISPR/Cas9 and homology-directed repair

Krishshan Gobalakrishnan,Vignesh Jayarajan,Veronica Kinsler,Wei-Li Di

DOI: https://doi.org/10.1093/bjd/ljae105.018

IF: 11.113

2024-05-17

British Journal of Dermatology

Abstract:Abstract Introduction and aims Keratitis–ichthyosis–deafness (KID) syndrome is an ectodermal disorder that causes blindness, skin inflammation and deafness. It is caused by autosomal dominant mutations in the gap junction beta 2 (GJB2) gene with 86% being a hotspot mutation on c.148G>A, resulting in the amino acid replacement (D50N) in its coding protein connexin 26 (Cx26). There is currently no curative treatment for KID syndrome. We aim to correct the hotspot mutation D50N using a genome-editing approach. Methods Keratinocytes generated from the patient with KID who had a D50N mutation (KID-KCs) were genetically corrected by homologous-directed repair/CRISPR-Cas9 using an electroporation approach. The correction efficiency was determined and analysed using Sanger sequencing and Synthego Inference of CRISPR Edits analysis. The off-target effects were confirmed by whole-exome sequencing [exome next-generation sequencing (NGS)]. Furthermore, the functional recovery following genome editing was assessed by GJB2 mRNA production, Cx26 protein expression, and trafficking and hemichannel activity. Results The correction efficiencies ranged from 95% to 100% with different doses of CRISPR-Cas9 and 8μg CRISPR-Cas9 was the most optimal concentration with the efficiency of 100% and approximately 0% insertion-deletion (INDEL). Fifty days after gene editing, the INDEL increased to only 2%, indicating a minimum residual CRISPR-Cas9 effect in edited cells. The exome-NGS analysis also showed no off-target effects in the outside target area. Functional studies showed that there was a significant increase in wildtype GJB2 mRNA expression and a reduction of mutant GJB2 expression (n = 5, P < 0.01). Increased Cx26 membranous localization in KID-KCs was also observed (n = 3, P < 0.01). Additionally, Cx26 hemichannel activity assessment using the neurobiotin assay showed a significant decrease in ‘leaky’ hemichannel in gene-edited KID-KCs compared with unedited cells (n = 3, P < 0.05). Conclusions We can genome-correct KID keratinocytes harbouring the mutation D50N with 100% editing efficiency, 0–2% INDEL, and undetectable off-target effects. This result indicates a promising gene therapy for KID syndrome with the hotspot mutation D50N.

dermatology
A Case of Noonan Syndrome and Kyrle Disease: Casualty or Causality?

Marco Brusasco,Arlind Kalaja,Francesca Satolli,Claudio Feliciani,Maria Beatrice De Felici Del Giudice

Abstract:A 39-year-old Caucasian woman affected by Noonan Syndrome (NS) mutated in RAF1 was referred to us with itchy lesions on her limbs that had appeared two months earlier. Clinically, there were multiple umbilicated papules with a hyperkeratotic central plug, localized on the upper and lower limbs (Figure 1, a-b). The patient had no personal history of diabetes mellitus or chronic renal failure, but suffered from hypertrophic cardiomyopathy. Blood tests showed no abnormalities. On histological examination of a skin lesion, an ectatic hair follicle with a hyperkeratotic ostium was observed with fragments of hair, inflammatory cells, and epidermal perforation. A final diagnosis of Kyrle disease (KD) was established. The patient underwent narrowband UVB (NB-UVB) phototherapy with residual atrophic scars (Figure 1, c-d), but with a complete and long-lasting resolution of symptoms. KD belongs to perforating dermatoses (PD), a heterogeneous group of skin diseases characterized by the transepidermal elimination of dermal components. Despite the classification of PD still being under debate, four primary forms are traditionally recognized: reactive perforating collagenosis, elastosis perforans serpiginosum, perforating folliculitis, and KD (1). The typical skin manifestation of KD is an eruption of dome-shaped papules and nodules, with a whitish central keratotic plug, mainly localized on the extremities and the buttocks. Described by Kyrle in 1916, KD is frequently associated with systemic diseases, especially chronic renal failure and diabetes mellitus. Other associated conditions include chronic hepatic disease, internal malignancies, and congestive heart disease (1). Despite the absence of a consensus, the control of the underlying disease remains the first therapeutic target. Both topical (keratolytics, retinoids, and corticosteroids) and systemic treatments (corticosteroids, retinoids, antibiotics, and phototherapy) have been reported to control skin manifestations (2). In our experience, NB-UVB is an effective option as first-line therapy in case of diffuse lesions, both in KD and in other PD (3). NS is a relatively common RASopathy, a heterogenous group of genetic diseases characterized by a defect of the Ras-mitogen-activated protein kinase (Ras-MAPK) pathway, with an estimated prevalence of 1/1000-2500. PTPN11 is the most frequent mutated gene, accounting for 50% of cases, but more than ten genes have been identified as causing NS (4). Classical features include a distinctive facial dysmorphism, short stature, pulmonic stenosis, and other anomalies of different organs. The skin is commonly involved. Keratinization disorders and hair abnormalities such as keratosis pilaris, ulerythema ophryogenes, wavy or curly hair, and scarce scalp hair, are often described. Other cutaneous signs include easy bruising, skin hyperlaxity, multiple lentigines, and café-au-lait spots (5). To the best of our knowledge, no cases of KD in patients with NS have been previously reported to date. The exact etiopathogenesis of KD is not clear, but it has been hypothesized that systemic diseases, such as diabetes and chronic renal failure, can cause a deposit of substances or dermis alterations, which triggers the inflammatory process with subsequent transepidermal extrusion (1). In our patient, we ruled out all the causes commonly associated with KD. It is however possible that this manifestation could be a direct result of the patient's illness. Our patient suffered from diffuse keratosis pilaris, and an abnormal epidermal keratinization with a secondary inflammatory dermic response is among the suggested possible pathogenetic mechanisms of KD (1). On the other hand, the hyperlaxity and fragility of the skin typical of NS suggest the presence of altered connective tissue, which could trigger an abnormal keratinization and, subsequently, the transepidermal extrusion, as well as perforating elastosis, which is associated with genetic connective tissue diseases (1). Moreover, our patient suffered from a cardiac disease, another condition associated with KD (5). Although these explanations have their appeal, there is currently insufficient evidence of a link between KD and NS, and it will be necessary to collect additional data to confirm this hypothesis.
Gain-of-Function KIDINS220 Variants Disrupt Neuronal Development and Cause Cerebral Palsy

Jin Zhang,Yandong Zhang,Qing Shang,Ye Cheng,Yu Su,Junjie Zhang,Ting Wang,Jian Ding,Yunqian Li,Yunli Xie,Qinghe Xing

DOI: https://doi.org/10.1002/mds.29694

IF: 9.698

2024-01-01

Movement Disorders

Abstract:Background: Kinase D-interacting substrate of 220 kDa (KIDINS220) is a multifunctional scaffolding protein essential for neuronal development. It has been implicated in neurological diseases with either autosomal dominant (AD) or autosomal recessive (AR) inheritance patterns. The molecular mechanisms underlying the AR/AD dual nature of KIDINS220 remain elusive, posing challenges to genetic interpretation and clinical interventions. Moreover, increased KIDINS220 exhibited neurotoxicity, but its role in neurodevelopment remains unclear.Objective: The aim was to investigate the genotype-phenotype correlations of KIDINS220 and elucidate its pathophysiological role in neuronal development.Methods: Whole-exome sequencing was performed in a four-generation family with cerebral palsy. CRISPR/Cas9 was used to generate KIDINS220 mutant cell lines. In utero electroporation was employed to investigate the effect of KIDINS220 variants on neurogenesis in vivo.Results: We identified in KIDINS220 a pathogenic nonsense variant (c.4177C > T, p.Q1393*) that associated with AD cerebral palsy. We demonstrated that the nonsense variants located in the terminal exon of KIDINS220 are gain-of-function (GoF) variants, which enable the mRNA to escape nonsense-mediated decay and produce a truncated yet functional KIDINS220 protein. The truncated protein exhibited significant resistance to calpain and consequently accumulated within cells, resulting in the hyperactivation of Rac1 and defects in neuronal development.Conclusions: Our findings demonstrate that the location of variants within KIDINS220 plays a crucial role in determining inheritance patterns and corresponding clinical outcomes. The proposed interaction between Rac1 and KIDINS220 provides new insights into the pathogenesis of cerebral palsy, implying potential therapeutic perspectives. (c) 2023 International Parkinson and Movement Disorder Society.
Genetic and Clinical Analyses of the KIZ-c.226C>T Variant Resulting in a Dual Mutational Mechanism

Yogapriya Sundaresan,Antonio Rivera,Alexey Obolensky,Prakadeeswari Gopalakrishnan,Hanit Ohayon Hadad,Aya Shemesh,Samer Khateb,Maya Ross,Ron Ofri,Sharon Durst,Hadas Newman,Rina Leibu,Shiri Soudry,Dinah Zur,Tamar Ben-Yosef,Eyal Banin,Dror Sharon

DOI: https://doi.org/10.3390/genes15060804

IF: 4.141

2024-06-19

Genes

Abstract:Retinitis pigmentosa (RP) is a heterogeneous inherited retinal disorder. Mutations in KIZ cause autosomal recessive (AR) RP. We aimed to characterize the genotype, expression pattern, and phenotype in a large cohort of KIZ cases. Sanger and whole exome sequencing were used to identify the KIZ variants. Medical records were reviewed and analyzed. Thirty-one patients with biallelic KIZ mutations were identified: 28 homozygous for c.226C>T (p.R76*), 2 compound heterozygous for p.R76* and c.3G>A (p.M1?), and one homozygous for c.247C>T (p.R83*). c.226C>T is a founder mutation among patients of Jewish descent. The clinical parameters were less severe in KIZ compared to DHDDS and FAM161A cases. RT-PCR analysis in fibroblast cells revealed the presence of four different transcripts in both WT and mutant samples with a lower percentage of the WT transcript in patients. Sequence analysis identified an exonic sequence enhancer (ESE) that includes the c.226 position which is affected by the mutation. KIZ mutations are an uncommon cause of IRD worldwide but are not rare among Ashkenazi Jews. Our data indicate that p.R76* affect an ESE which in turn results in the pronounced skipping of exon 3. Therefore, RNA-based therapies might show low efficacy since the mutant transcripts are spliced.

genetics & heredity
A Novel Mutation in MBTPS2 Causes a Broad Phenotypic Spectrum of Ichthyosis Follicularis, Atrichia, and Photophobia Syndrome in a Large Chinese Family

Li Tang,Jianying Liang,Wenzhang Wang,Long Yu,Zhirong Yao

DOI: https://doi.org/10.1016/j.jaad.2010.02.045

IF: 15.487

2011-01-01

Journal of the American Academy of Dermatology

Abstract:Background. Ichthyosis follicularis, atrichia, and photophobia (IFAP) syndrome is a rare congenital disorder. Missense mutations in the membrane-bound transcription factor protease, site 2 (MBTPS2) gene have recently been identified in patient g with IFAP.Objective: To determine whether Chinese patients with IFAP have MBTPS2 mutations.Methods: We observed a large IFAP pedigree of 5 generations in a Chinese family and performed MBTPS2 molecular analysis.Results: The male proband was severely affected. He presented with hyperextensibility of the interphalangeal joints of the fingers in addition to previously reported clinical manifestations. Clinically affected female patients had hairless patches on the scalp, ichthyosiform skin changes, hypotrichosis, hyperkeratosis, nail dystrophy, and brown scaly plaques, some of which were arranged in a linear pattern following the lines of Blaschko. Molecular analysis identified a novel missense mutation in exon 11 and confirmed cosegregation of the missense mutation with the disease in this family.Limitations: It is unclear whether hyperextensibility of the fingers was nosologically related to IFAP syndrome or was a coincidental finding.Conclusion: This report provides further evidence for the genetic basis of IFAP syndrome and enlarges the phenotypic spectrum and number of MBTPS2 mutations. We confirm that MBTPS2 mutations cause IFAP in patients of Chinese origin. (J Am Acad Dermatol 2011;64:716-22.)
Unilateral Focal Palmoplantar Keratoderma Associated with a Postzygotic Variant in PIK3CA and Activation of the PI3K/AKT/mTOR Pathway.

Zhuoqing Gong,Sha Peng,Huijun Wang,Xingyuan Jiang,Xiaoping Ke,Zhimiao Lin

DOI: https://doi.org/10.1684/ejd.2024.4704

2024-01-01

European Journal of Dermatology

Abstract:Background: : Palmoplantar keratoderma (PPK) is a group of disorders with genetic and phenotypic heterogeneity featuring skin thickening of the palms and soles. More than 60 genes involved in various biological processes are implicated in PPK. PIK3CA is an oncogene encoding p110 alpha, and its somatic variants contribute to a spectrum of congenital overgrowth disorders, including epidermal nevi (EN). Objectives: : To identify the genetic basis and elucidate the pathogenesis of a patient with unilateral focal PPK. Materials & Methods: : Whole-exome sequencing and Sanger sequencing combined with laser capture microdissection (LCM) were performed on genomic DNA extracted from the patient's peripheral blood and skin lesion. Skin biopsies were taken from the lesion of the patient and normal controls for immunofluorescence. Molecular docking was performed using Alphafold2-multimer. Results: : A three-year-old girl presented with unilateral focal PPK with an identified missense variant (c.3140A>G, p.His1047Arg) in PIK3CA from affected tissue. This variant only existed in the lesional epidermis. Elevated PI3K/AKT/mTOR signalling in the affected epidermis and an increased number of Ki67-positive keratinocytes were demonstrated. Molecular docking indicated instability of the p110 alpha-p85 alpha dimer caused by the PIK3CA His1047Arg variant. Conclusion: : We describe the first PPK case associated with a variant in PIK3CA, , which expands the spectrum of PIK3CA-related disorders. Our study further underscores the importance of the PI3K/AKT/mTOR pathway in the homeostasis of skin keratinization.
P02 Erythrokeratodermia variabilis et progressiva due to a pathogenic variant in GJB3 gene

Maria Bageta,Pablo Lopez Balboa,Debra Lomas,Gabriela Petrof,Anna E Martinez

DOI: https://doi.org/10.1093/bjd/ljad483.012

IF: 11.113

2024-01-01

British Journal of Dermatology

Abstract:Abstract Erythrokeratodermia variabilis et progressiva (EKVP) is a clinically heterogeneous group of inherited disorders characterized by the coexistence of localized or generalized hyperkeratotic plaques and transient, stationary or migratory erythematous patches. EKPV is most often transmitted in an autosomal dominant manner. Causal pathogenic variants have been detected in the GJB3, GJB4, GJA1 KDSR and KRT83 genes encoding connexins 31, 30.3, 43, 3-ketodihydrosphingosine reductase and keratin 83, respectively. Connexins are expressed in almost all tissues and pathogenic variants in the connexin genes can cause skin diseases, cardiovascular disorders, myelin-related diseases, craniofacial disorders and hearing loss. We present a 2-year-old girl who was referred to our centre with well-demarcated hyperkeratotic plaques symmetrically distributed with a predilection for the distal extremities and buttocks as well as erythematous plaques on her cheeks. The hyperkeratotic plaques were hyperpigmented, exhibited a geographic morphology and had prominent hypertrichosis. Her trunk and upper extremities were spared and her hair, teeth and nails were normal. There was family history of mild psoriasis in her mother and mild eczema in her father. Next generation sequencing confirmed she was heterozygous for the GJB3 c.625C>T p.(Leu209Phe) pathogenic variant which is associated with erythrokeratodermia variabilis et progressiva-1 (MIM 133200) and autosomal dominant deafness-2B (MIM 612644). Erythrokeratodermia variabilis is largely a skin-limited condition however GJB3 pathogenic variants can cause haring loss and neuropathy due to its expression in peripheral nerves and the cochlea. Our patient’s hearing and development have been normal to date and will be monitored.

dermatology
Ichthyosis Follicularis, Alopecia, and Photophobia Syndrome in a Saudi Child: A Case Report

Nouf F Bin Rubaian,Bashayer S Al-Awam,Abdulelah Hassan Alluhaybi,Ahmed Abdulaziz Alsaati

DOI: https://doi.org/10.2147/CCID.S439288

2023-12-07

Abstract:Ichthyosis follicularis, atrichia, and photophobia (IFAP) syndrome is a rare autosomal recessive, X-linked, genetic disorder that involves a triad of follicular ichthyosis, atrichia of the scalp, and photophobia. We report a case of an 8-year-old boy with alopecia of the scalp, eyebrows, and eyelashes, which occurred in his first year of age. His birth was uneventful, and his developmental milestones were normal. The alopecia was non-scarring and was accompanied by mild generalized xerosis, photophobia, and recurrent angular cheilitis. Moreover, numerous non-inflammatory, follicular, keratotic tiny papules were noticed. His deciduous teeth had retention with gum hyperplasia, and his feet showed symmetrical plantar keratoderma and nail dystrophy of the right big toe. The genetic testing confirmed an X-linked recessive inheritance of IFAP syndrome without BRESHECK syndrome due to the mutation in the MBTPS2 (300294) gene located on chromosome Xp22.12. The patient was given symptomatic treatment with urea cream for plantar keratoderma and was advised to apply constant moisturizers to avoid generalized xerosis. Dermatological and ophthalmological follow-ups were recommended. This is the first case reported from Saudi Arabia. This case report throws light on the characteristics of IFAP syndrome and denotes the points of differentiation from similar conditions.
Clinical, Immunological, and Genetic Features in Patients with Activated PI3Kδ Syndrome (APDS): a Systematic Review

Mahnaz Jamee,Shakiba Moniri,Majid Zaki-Dizaji,Peter Olbrich,Reza Yazdani,Farhad Jadidi-Niaragh,Fatemeh Aghamahdi,Hassan Abolhassani,Alison M Condliffe,Asghar Aghamohammadi,Gholamreza Azizi

DOI: https://doi.org/10.1007/s12016-019-08738-9

Abstract:Activated phosphoinositide 3-kinase delta syndrome (APDS) is a novel primary immunodeficiency (PID) caused by heterozygous gain of function mutations in PI3Kδ catalytic p110δ (PIK3CD) or regulatory p85α (PIK3R1) subunits leading to APDS1 and APDS2, respectively. Patients with APDS present a spectrum of clinical manifestations, particularly recurrent respiratory infections and lymphoproliferation. We searched PubMed, Web of Science, and Scopus databases for APDS patients and screened for eligibility criteria. A total of 243 APDS patients were identified from 55 articles. For all patients, demographic, clinical, immunologic, and molecular data were collected. Overall, 179 APDS1 and 64 APDS2 patients were identified. The most common clinical manifestations were respiratory tract infections (pneumonia (43.6%), otitis media (28.8%), and sinusitis (25.9%)), lymphoproliferation (70.4%), autoimmunity (28%), enteropathy (26.7%), failure to thrive (20.6%), and malignancy (12.8%). The predominant immunologic phenotype was hyper-IgM syndrome (48.1%). Immunologic profiling showed decreased B cells in 74.8% and CD4+ T cells in 64.8% of APDS patients. The c.3061 G>A (p. E1021K) mutation in APDS1 with 85% frequency and c.1425+1 G> (A, C, T) (p.434-475del) mutation in APDS2 with 79% frequency were hotspot mutations. The majority of APDS patients were placed on long-term immunoglobulin replacement therapy. Immunosuppressive agents such as rituximab, tacrolimus, rapamycin, and leniolisib were also administered for autoimmunity and inflammatory complications. In addition, hematopoietic stem cell transplantation (HSCT) was used in 12.8% of patients. APDS has heterogynous clinical manifestations. It should be suspected in patients with history of recurrent respiratory infections, lymphoproliferation, and raised IgM levels. Moreover, HSCT should be considered in patients with severe and complicated clinical manifestations with no or insufficient response to the conventional therapies.

Ross operation in a patient with juvenile rheumatoid arthritis.

Severe KIDAR syndrome caused by deletion in the AP1B1 gene: Report of a teenage patient and systematic review of the literature

Integrated Facial Analysis and Targeted Sequencing Identifies a Novel KDM6A Pathogenic Variant Resulting in Kabuki Syndrome

Intersession repeatability of visual acuity scores in age-related macular degeneration.

Poster presentationsSG11 KRT14 pathogenic or likely pathogenic variants beyond epidermolysis bullosa: dermatopathia pigmentosa reticularis

Antibody Deficiency in Patients with Biallelic KARS1 Mutations

Biallelic variants in KARS1 are associated with neurodevelopmental disorders and hearing loss recapitulated by the knockout zebrafish

A Rare Deep Intronic Mutation of PKHD1 Gene, C.8798-459 C > A, Causes Autosomal Recessive Polycystic Kidney Disease by Pseudoexon Activation

Leopard-like retinopathy and severe early-onset portal hypertension expand the phenotype of KARS1-related syndrome: a case report

PI4K2A deficiency causes innate error in intracellular trafficking with developmental and epileptic-dyskinetic encephalopathy

Genetic and phenotypic heterogeneity in KIAA0753-related ciliopathies

A Case of Noonan Syndrome and Kyrle's Disease: Coincidence or Causality?

O18 Precision genome editing for targeted correction of pathogenic D50N mutation in keratitis–ichthyosis–deafness syndrome using CRISPR/Cas9 and homology-directed repair

A Case of Noonan Syndrome and Kyrle Disease: Casualty or Causality?

Gain-of-Function KIDINS220 Variants Disrupt Neuronal Development and Cause Cerebral Palsy

Genetic and Clinical Analyses of the KIZ-c.226C>T Variant Resulting in a Dual Mutational Mechanism

A Novel Mutation in MBTPS2 Causes a Broad Phenotypic Spectrum of Ichthyosis Follicularis, Atrichia, and Photophobia Syndrome in a Large Chinese Family

Unilateral Focal Palmoplantar Keratoderma Associated with a Postzygotic Variant in PIK3CA and Activation of the PI3K/AKT/mTOR Pathway.

P02 Erythrokeratodermia variabilis et progressiva due to a pathogenic variant in GJB3 gene

Ichthyosis Follicularis, Alopecia, and Photophobia Syndrome in a Saudi Child: A Case Report

Clinical, Immunological, and Genetic Features in Patients with Activated PI3Kδ Syndrome (APDS): a Systematic Review